Sprinklr (CXM) Insider Plans $1 M Share Sale Under Rule 144 Filing
Rhea-AI Filing Summary
Sprinklr, Inc. (NYSE: CXM) – Form 144 insider sale notice
Officer Scott Michael Harvey has filed a Form 144 indicating an intent to sell 121,057 Class A common shares through Morgan Stanley Smith Barney on or after 26 June 2025. Based on the filing’s stated aggregate market value of $995,088.54, the planned sale represents roughly 0.085% of the 142,831,141 shares outstanding. The securities were acquired via restricted-stock-unit (RSU) vesting on 15 December 2024 and 15 March 2025.
The officer previously sold 13,964 shares for $114,085.88 on 16 June 2025. A written Rule 10b5-1 trading plan was adopted on 27 March 2025, and the filer certifies that no undisclosed material adverse information is known. The filing is LIVE and was signed on 26 June 2025.
Key takeaways
- Proposed sale size is modest in relation to total shares but could be monitored for continued insider selling trends.
- Use of a 10b5-1 plan and timely Form 144 filing indicates procedural compliance and mitigates information asymmetry concerns.
- No financial performance data or strategic updates are included; the document focuses solely on the intended disposition of insider-held shares.
Positive
- Use of a pre-arranged Rule 10b5-1 trading plan (adopted 03/27/2025) enhances transparency and reduces insider-trading risk.
Negative
- Officer intends to sell 121,057 shares (~$1.0 million), signalling insider liquidation albeit modest in percentage terms.
- Prior sale of 13,964 shares within the last three months indicates an ongoing disposition trend.
Insights
TL;DR – Small insider sale; neutral market impact given size and 10b5-1 plan.
The proposed divestiture of 121,057 shares (≈0.085% of shares outstanding) is immaterial to CXM’s float and trading liquidity. Gross proceeds of about $1 million are negligible versus Sprinklr’s market capitalization. Adoption of a 10b5-1 plan on 27 March 2025 reduces potential signalling risk and suggests the transaction is pre-programmed rather than event-driven. Although repeat sales (13,964 shares earlier in June) warrant observation, the data provided do not indicate fundamental issues at the company. I therefore view the filing as neutral for valuation and stock performance.
TL;DR – Routine Rule 144 filing; minor negative optics due to ongoing officer sales.
From a governance lens, Harvey’s continued share disposals shortly after RSU vesting may raise questions about long-term alignment, even if dollar amounts are small. Nonetheless, strict adherence to Rule 144 disclosure, live filing status, and the presence of a 10b5-1 plan demonstrate sound compliance practices. Given the limited scale, I classify the event as not materially impactful, but investors may monitor insider-sale velocity for trend changes.